Episodes of General Medicine and Primary Care

From Awareness to Action: What To Do With a Positive OSA Screen?

Host: Kevin Trice, MD One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencing symptoms of OSA,

Overcoming Hurdles: Effective OSA Screening in Primary Care

Host: Anne Marie Morse, DO, FAASM One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencing sympt

Host: Michael E. Yurcheshen, MD, FAASM One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencing

How to Screen for OSA

OSA: Exploring the Impact on Morbidity and Mortality

Host: Seema Khosla, MD, FCCP, FAASM One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencing sym

CASR and ADH1: Integrating Biology and Genetic Screening

Host: Alcibiades J. Rodriguez, MD, FAASM One billion people worldwide are estimated to have Obstructive Sleep Apnea (OSA). There is strong data linking OSA with morbidity and mortality. Many of your patients are likely experiencin

Therapeutic Options for ADH1 and Hypoparathyroidism

Host: Michael A. Levine, MD, FAAP, MACE, FACP Host: B. Michelle Schweiger, DO, MPH Autosomal Dominant Hypocalcemia Type 1 (ADH1) is caused by gain-of-function variants of the CASR gene encoding the calcium-sensing receptor (Ca

Emerging Therapeutics in ADH1: Progress in Precision Medicine

Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism

5 Things You Need to Know About Epilepsy & Depression

Feb 29th, 2024

Host: Heidi M. Munger Clary, MD, MPH Guest: Jay Salpekar, MD, FANPA A crucial aspect of epilepsy care that often goes underappreciated is the intersection of epilepsy and depression. Join Drs. Munger Clary and Salpekar, leadin

Improving Outcomes in Patients with RVO: Tailoring Treatment

Feb 21st, 2024

Guest: Carl Danzig, MD Guest: Arshad M. Khanani, MD, MA Dr. Carl Danzig, Director of Vitreoretinal Services and Retina Clinical Research of Rand Eye Institute in Deerfield Beach, Florida, and Dr. Arshad Khanani, Clinical Assoc

Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments

Feb 20th, 2024

Host: Scott Kahan, MD, MPH Guest: Ken Fujioka, MD Guest: Carol Wysham, MD Embark on a transformative journey to redefine patient care for individuals with type 2 diabetes by transitioning from the conventional focus on gly

Systemic Gout Uncovered: Primary Care Perspectives and Solutions

Feb 2nd, 2024

Host: John K. Botson, MD, RPh Guest: Xu He, MD Many patients with gout don’t achieve their target urate levels with conventional urate-lowering therapies. Join renowned experts Drs. Xu He and John Botson as they dissect the po

Expanding Screening, Improving Treatment Acceptance, and Optimizing Outcomes for Patients with Moderate to Severe Alcohol Use Disorder (AUD)

Jan 17th, 2024

Host: Annie Levesque, MD, MSc Guest: Ethan A. Cowan, MD Alcohol use disorder, or AUD, is a rising health crisis that often goes undiagnosed. And many patients that are diagnosed with AUD do not receive appropriate pharmacologi

Postpartum Depression: A Significant Burden and a Novel Approach to Treatment

Dec 5th, 2023

Host: Lee Shulman MD, FACOG, FACMG Guest: Kristina Deligiannidis, MD The recent development and approval of two neuroactive steroids is likely to change the treatment paradigm for moderate to severe postpartum depression (PPD)

Postpartum Depression: A Significant Burden and a Novel Approach to Treatment

Dec 5th, 2023

Addressing Issues of CV Mortality in Clinical Trials with IV Iron: Are We Still Getting a Medical Benefit?

Dec 1st, 2023

Host: Stefan D. Anker, MD, PhD Guest: John Cleland, MD Guest: Piotr Ponikowski, MD, PhD, FESC, FHFA Iron deficiency is a common heart failure comorbidity with a negative impact on patients’ quality of life and mortality. R

Addressing Issues of CV Mortality in Clinical Trials with IV Iron: Are We Still Getting a Medical Benefit?

Dec 1st, 2023

The DOAC Revolution: What Have We Learned?

While the DOAC Revolution Has Occurred, 40-50% of Patients Remain Untreated... Why?

Host: Christopher B. Granger, MD Anticoagulation has transformed the management of multiple potentially catastrophic disease states. Currently, available anticoagulation agents work on the common pathway of the coagulation cascade

The Path Forward: What’s On The Horizon?

Host: Elaine Hylek, MD, MPH Anticoagulation has transformed the management of multiple potentially catastrophic disease states. Currently, available anticoagulation agents work on the common pathway of the coagulation cascade, inh

Taking the Patient-Centered Approach to Mycophenolate Risk Mitigation

Host: Manesh R. Patel, MD Anticoagulation has transformed the management of multiple potentially catastrophic disease states. Currently, available anticoagulation agents work on the common pathway of the coagulation cascade, inhib

While DOACs are Good for Some Things, They Are Not for Everyone

Guest: Cara Dolin, MD Guest: Jennifer Simpson Guest: Diana Girnita, MD ,PhD Explore this video roundtable featuring an interdisciplinary panel of experts discussing a woman’s journey with mycophenolate therapy and strategi

Questions & Answers from the AHA 2023 Symposium

Host: M. Cecilia Bahit, MD Anticoagulation has transformed the management of multiple potentially catastrophic disease states. Currently, available anticoagulation agents work on the common pathway of the coagulation cascade, inhi